Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Remaining Performance Obligations (RPO) by Quarter
Remaining Performance Obligations (RPO) — Total [legacy through Q3 2023] ($M) ($M)
Pfizer Remaining Performance Obligations (RPO): $9,000M in Q3 2023, down 59.1% from a year earlier. That is the lowest of the 8 quarters on record here. No newer figure appears in the documents we track.
Where the Q3 2023 figure comes from
Source: Form 10-Q (filed 2023-11-08) ↗
Reported in Form 10-Q / 10-K Revenue Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Remaining Performance Obligations (RPO) — Total [legacy through Q3 2023] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2023 | Oct 1, 2023 | 9,000 | -59.1% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 9,000 | -62.5% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 13,000 | -56.7% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 15,000 | -56.4% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2022 | Oct 2, 2022 | 22,000 | – | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 24,000 | – | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 30,000 | – | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 34,400 | – | Form 10-K (filed 2022-02-24) ↗ |
Cite this data
StockData. (2026). Pfizer Remaining Performance Obligations (RPO) ($M), quarterly Q4 2021–Q3 2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/rpo-total-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.